 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
|
|
|
|
Phase IV
|
|
|
|
Hemato INCAN 01/2007
NCT00429065
|
|
| |
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
|
|
|
|
Phase IV
|
|
|
|
2006-00055-18
NCT00415103
|
|
| |
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
|
|
| |
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
|
|
|
|
Phase III, Phase II
|
|
|
|
Levosta-CBF-02/04
NCT00215007
|
|
| |
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
|
|
|
|
Phase III, Phase II
|
|
|
|
GC P#02.01.001
NCT00469729
|
|
| |
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
|
|
|
|
Phase III, Phase II
|
|
|
|
RPCI-I-72806
I 72806, NCT00536601
|
|
| |
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
|
|
|
|
Phase III
|
|
|
|
EORTC-58951
NCT00003728
|
|
| |
Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma
|
|
|
|
Phase III
|
|
|
|
FRE-IGR-ALCL99
EU-20031, NHL2000/06, NCT00006455
|
|
| |
Total-Body Irradiation With Or Without Fludarabine Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
|
|
|
|
Phase III
|
|
|
|
FHCRC-1813.00
5666, NCT00075478
|
|
| |
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
|
|
|
|
Phase III
|
|
|
|
HLMCC-0402
NCT00369564, ACCL 0731
|
|
